<VariationArchive VariationID="426114" VariationName="NM_002968.3(SALL1):c.1108_1109del (p.Val370fs)" VariationType="Deletion" Accession="VCV000426114" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-30" DateCreated="2017-05-22" MostRecentSubmission="2017-05-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="414718" VariationID="426114">
      <GeneList>
        <Gene Symbol="SALL1" FullName="spalt like transcription factor 1" GeneID="6299" HGNC_ID="HGNC:10524" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="51135982" stop="51152334" display_start="51135982" display_stop="51152334" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="51169885" stop="51185182" display_start="51169885" display_stop="51185182" Strand="-" />
          </Location>
          <OMIM>602218</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SALL1">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SALL1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002968.3(SALL1):c.1108_1109del (p.Val370fs)</Name>
      <CanonicalSPDI>NC_000016.10:51141112:AC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="51141113" stop="51141114" display_start="51141113" display_stop="51141114" variantLength="2" positionVCF="51141112" referenceAlleleVCF="GAC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="51175024" stop="51175025" display_start="51175024" display_stop="51175025" variantLength="2" positionVCF="51175023" referenceAlleleVCF="GAC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>V273fs</ProteinChange>
      <ProteinChange>V370fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.51141113_51141114del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.51141113_51141114del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.51175024_51175025del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.51175024_51175025del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007990.1" sequenceAccession="NG_007990" sequenceVersion="1" change="g.15159_15160del">
            <Expression>NG_007990.1:g.15159_15160del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127892.2" sequenceAccession="NM_001127892" sequenceVersion="2" change="c.817_818del">
            <Expression>NM_001127892.2:c.817_818del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121364.1" sequenceAccession="NP_001121364" sequenceVersion="1" change="p.Val273fs">
            <Expression>NP_001121364.1:p.Val273fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002968.3" sequenceAccession="NM_002968" sequenceVersion="3" change="c.1108_1109del" MANESelect="true">
            <Expression>NM_002968.3:c.1108_1109del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002959.2" sequenceAccession="NP_002959" sequenceVersion="2" change="p.Val370fs">
            <Expression>NP_002959.2:p.Val370fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_674" sequenceAccession="LRG_674">
            <Expression>LRG_674:g.15159_15160del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002968.2" sequenceAccession="NM_002968" sequenceVersion="2" change="c.1108_1109delGT">
            <Expression>NM_002968.2:c.1108_1109delGT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645294090" DB="ClinGen" />
        <XRef Type="rs" ID="1085307143" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002968.3(SALL1):c.1108_1109del (p.Val370fs) AND Townes-Brocks syndrome 1" Accession="RCV000489064" Version="2">
        <ClassifiedConditionList TraitSetID="2021">
          <ClassifiedCondition DB="MedGen" ID="C4551481">Townes-Brocks syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-04-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-04-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-05-22" MostRecentSubmission="2017-05-22">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="2021" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6067" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DEAFNESS, SENSORINEURAL, WITH IMPERFORATE ANUS AND THUMB ANOMALIES</ElementValue>
                <XRef Type="MIM" ID="107480" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Townes-Brocks syndrome 1</ElementValue>
                <XRef ID="MONDO:0054581" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Renal-ear-anal-radial syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anus, imperforate, with hand, foot and ear anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness, sensorineural, with imperforate anus and hypoplastic thumbs</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TBS1</ElementValue>
                <XRef Type="MIM" ID="107480" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">TBS</ElementValue>
                <XRef ID="GTR000528876" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Townes-Brocks syndrome (TBS) is characterized by the triad of imperforate anus (84%), dysplastic ears (87%; overfolded superior helices and preauricular tags; frequently associated with sensorineural and/or conductive hearing impairment [65%]), and thumb malformations (89%; triphalangeal thumbs, duplication of the thumb [preaxial polydactyly], and rarely hypoplasia of the thumbs). Renal impairment (42%), including end-stage renal disease (ESRD), may occur with or without structural abnormalities (mild malrotation, ectopia, horseshoe kidney, renal hypoplasia, polycystic kidneys, vesicoutereral reflux). Congenital heart disease occurs in 25%. Foot malformations (52%; flat feet, overlapping toes) and genitourinary malformations (36%) are common. Intellectual disability occurs in approximately 10% of individuals. Rare features include iris coloboma, Duane anomaly, Arnold-Chiari malformation type 1, and growth retardation.</Attribute>
                <XRef ID="NBK1445" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301618</ID>
                <ID Source="BookShelf">NBK1445</ID>
              </Citation>
              <XRef ID="857" DB="Orphanet" />
              <XRef ID="C4551481" DB="MedGen" />
              <XRef ID="MONDO:0054581" DB="MONDO" />
              <XRef Type="MIM" ID="107480" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1122709" SubmissionDate="2017-05-19" DateLastUpdated="2017-05-22" DateCreated="2017-05-22">
        <ClinVarSubmissionID localKey="ADMI00003|OMIM:107480" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000575934" DateUpdated="2017-05-22" DateCreated="2017-05-22" Type="SCV" Version="2" SubmitterName="Geisinger Autism and Developmental Medicine Institute, Geisinger Health System" OrgID="506174" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The following ACMG criteria are met: PVS1 (Predicted null variant in gene with LOF mechanism of disease), PM2 (Absent from population databases), PP4 (Patient's phenotype is specific for gene). The patient's clinical presentation is consistent with Townes-Brockes syndrome (anal stenosis, dysplastic ears, autism, developmental delays, sleep disturbance). A renal ultrasound found small kidneys with punctate echogenic foci bilaterally, and nephrology diagnosed him with chronic kidney disease stage 3. He had a normal cardiology evaluation. Brain MRI showed delayed myelination. His mother, who carries this variant, required speech therapy as a child. She has a history of kidney stones, but had normal renal ultrasound and cardiology evaluations.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SALL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_002968.2:exon 2</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002968.2:c.1108_1109delGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="107480" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ADMI_Batch_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1122709" TraitType="Disease" MappingType="XRef" MappingValue="107480" MappingRef="OMIM">
        <MedGen CUI="C4551481" Name="Townes-Brocks syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

